Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients

Abstract

Among hospitalized adults with C. difficile, receipt of PPIs concurrent with C. difficile treatment was not associated with CDI recurrence. Black race, increased age, and increased comorbidities significantly predicted recurrence. Future studies should test interventions to prevent CDI recurrence among high-risk inpatients.